Citizens Jmp Reaffirms “Market Outperform” Rating for Addus HomeCare (NASDAQ:ADUS)

Addus HomeCare (NASDAQ:ADUS)‘s stock had its “market outperform” rating reissued by research analysts at Citizens Jmp in a research note issued on Monday,Benzinga reports. They currently have a $142.00 price objective on the stock. Citizens Jmp’s target price indicates a potential upside of 53.42% from the stock’s previous close.

Several other research analysts have also commented on ADUS. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Wall Street Zen cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. KeyCorp reiterated an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday, February 25th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a report on Wednesday, February 25th. Finally, Stephens cut their target price on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $131.22.

Addus HomeCare Price Performance

ADUS opened at $92.56 on Monday. The stock’s 50 day simple moving average is $96.74 and its 200 day simple moving average is $106.31. Addus HomeCare has a 1 year low of $89.76 and a 1 year high of $124.43. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. The firm has a market cap of $1.73 billion, a price-to-earnings ratio of 16.94, a PEG ratio of 1.25 and a beta of 0.92.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.52 by $0.10. The business had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.42 EPS. As a group, analysts predict that Addus HomeCare will post 6.24 earnings per share for the current year.

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 4,988 shares of Addus HomeCare stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $533,616.24. Following the transaction, the chief executive officer owned 185,514 shares in the company, valued at approximately $19,846,287.72. The trade was a 2.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brian Poff sold 2,041 shares of the stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total value of $218,346.18. Following the completion of the sale, the executive vice president owned 64,512 shares of the company’s stock, valued at $6,901,493.76. The trade was a 3.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 16,788 shares of company stock valued at $1,785,633. 4.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Addus HomeCare

A number of hedge funds have recently made changes to their positions in the business. Hohimer Wealth Management LLC raised its stake in Addus HomeCare by 3.4% during the 3rd quarter. Hohimer Wealth Management LLC now owns 2,709 shares of the company’s stock valued at $320,000 after purchasing an additional 88 shares during the period. Amalgamated Bank grew its holdings in Addus HomeCare by 1.8% during the 3rd quarter. Amalgamated Bank now owns 5,240 shares of the company’s stock valued at $618,000 after buying an additional 93 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its holdings in shares of Addus HomeCare by 2.5% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after buying an additional 103 shares in the last quarter. ProShare Advisors LLC boosted its position in shares of Addus HomeCare by 3.1% during the fourth quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock worth $379,000 after acquiring an additional 105 shares during the last quarter. Finally, CANADA LIFE ASSURANCE Co grew its stake in Addus HomeCare by 0.6% during the second quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock valued at $2,150,000 after acquiring an additional 106 shares in the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.